PCSK9 vaccine: so near, yet so far!
Eur Heart J
.
2021 Oct 14;42(39):4007-4010.
doi: 10.1093/eurheartj/ehab299.
Authors
Amirhossein Sahebkar
1
2
,
Amir Abbas Momtazi-Borojeni
3
4
,
Maciej Banach
5
Affiliations
1
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
2
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
3
Department of Medical Biotechnology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
4
Iran's National Elites Foundation, Tehran, Iran.
5
Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Lodz, Poland.
PMID:
34151957
DOI:
10.1093/eurheartj/ehab299
No abstract available
MeSH terms
Cholesterol, LDL
Humans
Proprotein Convertase 9*
Vaccines*
Substances
Cholesterol, LDL
Vaccines
PCSK9 protein, human
Proprotein Convertase 9